EPA-0989 – Cost-effectiveness of atypical antipsychotics (quetiapine, risperidone, aripiprazole or olanzapine) for the treatment of relapse prevention for bipolar disorder in russian federation

✍ Scribed by Komarov, I.; Kulikov, A.

• Book ID: 125821540
• Publisher: Elsevier Science
• Year: 2014
• Tongue: French
• Weight: 54 KB
• Volume: 29
• Category: Article
• ISSN: 0924-9338
• DOI: 10.1016/S0924-9338(14)78288-4